Bernard Le Foll
Bernard Le Foll, M.D., Ph.D., works as a Clinician/Scientist specialized in drug addiction. He works as the Head of the Translational Addiction Research Laboratory at the Center for Addiction and Mental Health and Associate Professor at University of Toronto in the Departments of Family and Community Medicine, Psychiatry, Pharmacology, and Institute of Medical Sciences, whose clinical activity is centered on drug dependence, notably nicotine and alcohol addiction. He received specialized training in drug addiction and behavioral and cognitive therapy at Paris University in France. He has written the French smoking cessation guideline and has been coordinator of clinical trials for treatment of tobacco dependence. He obtained a PhD in Pharmacology at INSERM and has performed a Fogarty Visiting Fellowship at the National Institutes of Health. His research evaluates novel therapeutic approaches using a combination of preclinical, genetic and brain imaging approaches. He has received scientific prizes and awards from the French Academy of Medicine, the American College for Neuropsychopharmacology, the College on Problems on Drug Dependence, the National Institutes of Health, the Society for Research on Nicotine and Tobacco, Pfizer Global Research Award on Nicotine Dependence, the Canadian Institutes for Health Research and NARSAD.
Biography Updated on 19 January 2011